SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT

这是一项在既往参加过盐酸噻加滨癫痫研究的患者中进行的开放性、非比较性、添加治疗、扩展研究。然而，在研究过程中，可能会逐渐停用伴随使用的AED，因此预计部分患者可能会实现盐酸噻加滨单药治疗。 本研究可在美国正在或已经进行盐酸噻加宾临床研究的任何研究中心进行。 本研究的目的是确定盐酸噻加宾作为癫痫长期治疗的安全性。

This is an open-lavel, noncomparative, add-on therapy, extension study in patient who have previously participated in a tiagabine HCL epilepsy study. However, during the course of the study concomitant AEDs may be gradually withdrawn so that some patients may be expected to achieve tiagabine HCL monotherapy. This study may be conducted at any site that is conducting or has conducted, tiagabin HCL clinical studies in the United States. The objective of this study is to determine the safety of tiagabine HCl as chronic therapy for epilepsy.